结直肠癌肺转移:立体定向放疗与楔形切除的局部失败风险比较
该单中心回顾性研究纳入2006至2016年接受楔形切除或立体定向体部放疗(SBRT)的结直肠癌肺转移患者,比较两种治疗后的局部复发风险。结果显示SBRT组局部复发风险显著高于楔形切除组,2年局部复发率分别为29.4%与14.1%,提示SBRT应保留用于因合并症无法手术的患者。
要点
- SBRT治疗结直肠癌肺转移的局部复发风险是楔形切除的3.28倍。
- 肿瘤每增大1厘米,局部复发风险增加38%。
- 楔形切除后每结节2年局部复发率为14.1%,SBRT后为29.4%。
核心结论
- 结直肠癌肺转移接受SBRT治疗的局部复发风险高于楔形切除。
- SBRT应保留用于因合并症无法手术切除的患者。
研究设计与样本
- 单中心回顾性研究,回顾2006至2016年接受SBRT或楔形切除的结直肠癌肺转移患者记录。
- 共381例患者,762次楔形切除和64疗程SBRT,治疗826个肺结节。
- 采用倾向评分匹配权重,以死亡为竞争事件,估计每个转移结节的局部复发风险。
关键数值与推荐
- 局部复发定义为CT上紧邻吻合钉线或放疗野内增大的结节。
临床怎么用
- 对可手术的结直肠癌肺转移患者,优先选择楔形切除以降低局部复发风险。
- SBRT仅用于因合并症无法手术的患者。
局限性
- 回顾性单中心设计,可能存在选择偏倚。
- SBRT组样本量较小(64疗程),可能影响统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Several options are available for the local treatment of colorectal pulmonary metastases; however, the efficacy of each treatment has not been well characterized. We compared the risk of local recurrence after wedge resection or stereotactic body radiation therapy for pulmonary metastases of colorectal origin. METHODS: We retrospectively reviewed records of patients treated for pulmonary colorectal metastases with stereotactic body radiation therapy or wedge resection from 2006 to 2016 at a single institution. Local recurrence was defined as an enlarging nodule either adjacent to the staple line or within the radiation field on computed tomography. Matching weights using the propensity score with death as a competing event was used to estimate the risk of local recurrence for each metastatic nodule. RESULTS: A total of 381 patients underwent 762 wedge resections and 64 courses of stereotactic body radiation therapy for definitive treatment of 826 pulmonary nodules. The risk of local recurrence was increased with stereotactic body radiation therapy (hazard ratio, 3.28; 95% confidence interval, 1.53-7.04; P = .002) and larger tumor size (hazard ratio, 1.38 per additional centimeter; 95% confidence interval, 1.01-1.87; P = .042). After reweighting with matching weights, the marginal 2-year risk of local recurrence for each nodule was 14.1% (95% confidence interval, 9.8-18.5) after wedge resection and 29.4% (95% confidence interval, 13.8-45.0) after stereotactic body radiation therapy (P = .023). CONCLUSIONS: Pulmonary colorectal metastases treated with stereotactic body radiation therapy have a higher risk of local recurrence than those treated with wedge resection. Stereotactic body radiation therapy should be reserved for patients with comorbidities precluding surgical resection.
引用
- Nelson DB, Tayob N, Nguyen QN, et al. Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases. J Thorac Cardiovasc Surg. 2019. PMID: 31395367. doi:10.1016/j.jtcvs.2019.02.133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。